$362.30 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Bio-Techne

Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences reporting segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and reagents, to the biotechnology community. The Protein Sciences segment also provides an array of platforms useful in various areas of protein analysis. The Diagnostics and Genomics reporting segment provides blood chemistry and blood gas quality controls, hematology instrument controls, diagnostics immunoassays and other bulk and custom reagents for the in vitro diagnostic market.

Stock Analysis

last close $353.18
1-mo return -1.9%
3-mo return -18.5%
avg daily vol. 276.49T
52-week high 543.85
52-week low 318.07
market cap. $13.9B
forward pe 40.3
annual div. 1.28
roe 13.9%
ltg forecast -
dividend yield 0.36%
annual rev. $1.1B
inst own. 97.5%

Subscribe now for daily local and international financial news